Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry

Study:

Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry

Rationale:

n/a

Purpose:

This will be a registry study that will enroll patients referred for an ECG treadmill test with nuclear myocardial perfusion imaging (MPI). The high frequency QRS (HFQRS) information will be recorded and analyzed automatically and simultaneous with the standard ECG signals by the HyperQ System. Results of subsequent tests performed on each patient will be collected and used to enhance the reliability of designating each patient as a CAD-negative (i.e., no significant coronary artery disease) or a CAD-positive (i.e., significant coronary artery disease).

Study Status: Recruiting

Recruiting:
Ritamarie F. Anselmo, BSN, RN 216-444-9229 ANSELMR@CCF.org

Condition Intervention Phase
Coronary Artery Disease n/a N/A

Verified by BSP Biological Signal Processing Ltd. March, 2012

Sponsored by: BSP Biological Signal Processing Ltd.
Information provided by: BSP Biological Signal Processing Ltd.
ClinicalTrials.gov identifier: NCT01325467

Study Type: Interventional

Study Design: Observational Model: Case-Only, Time Perspective: Prospective

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

Jamieson M Bourque, MD., Principal Investigator
Robert Schwartz, MD., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site